Insider Buying: Omega Healthcare Investors (NYSE:OHI) CEO Purchases $862,800.00 in Stock

Omega Healthcare Investors, Inc. (NYSE:OHI) CEO C Taylor Pickett acquired 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The shares were bought at an average price of $43.14 per share, for a total transaction of $862,800.00. Following the completion of the purchase, the chief executive officer owned 20,000 shares of the company’s stock, valued at approximately $862,800. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Omega Healthcare Investors Stock Performance

OHI stock opened at $43.54 on Friday. The company has a 50-day simple moving average of $41.52 and a 200 day simple moving average of $39.27. The company has a market capitalization of $12.87 billion, a P/E ratio of 26.88, a PEG ratio of 1.85 and a beta of 0.69. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. Omega Healthcare Investors, Inc. has a fifty-two week low of $35.04 and a fifty-two week high of $43.62.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 EPS for the quarter, topping analysts’ consensus estimates of $0.77 by $0.02. The company had revenue of $260.74 million for the quarter, compared to the consensus estimate of $262.48 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. Omega Healthcare Investors’s revenue was up 14.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. Sell-side analysts predict that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Monday, November 3rd will be given a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a yield of 6.2%. The ex-dividend date is Monday, November 3rd. Omega Healthcare Investors’s dividend payout ratio is 149.72%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on OHI shares. Wells Fargo & Company lifted their price target on Omega Healthcare Investors from $44.00 to $45.00 and gave the company an “overweight” rating in a research report on Tuesday, October 21st. Truist Financial raised their target price on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a “hold” rating in a research note on Wednesday, September 3rd. Scotiabank boosted their price target on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a “sector perform” rating in a research report on Thursday, August 28th. Raymond James Financial reissued an “outperform” rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Omega Healthcare Investors in a research report on Wednesday, October 8th. Five analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $44.29.

Institutional Investors Weigh In On Omega Healthcare Investors

A number of institutional investors and hedge funds have recently modified their holdings of OHI. Caitong International Asset Management Co. Ltd acquired a new position in shares of Omega Healthcare Investors in the 2nd quarter valued at $26,000. Smartleaf Asset Management LLC lifted its stake in Omega Healthcare Investors by 40.9% during the second quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust’s stock valued at $34,000 after buying an additional 268 shares in the last quarter. CENTRAL TRUST Co boosted its holdings in shares of Omega Healthcare Investors by 1,654.4% in the second quarter. CENTRAL TRUST Co now owns 1,000 shares of the real estate investment trust’s stock worth $37,000 after buying an additional 943 shares during the period. Salem Investment Counselors Inc. purchased a new position in shares of Omega Healthcare Investors in the third quarter worth approximately $39,000. Finally, Bayforest Capital Ltd raised its holdings in shares of Omega Healthcare Investors by 395.2% during the second quarter. Bayforest Capital Ltd now owns 1,129 shares of the real estate investment trust’s stock valued at $41,000 after acquiring an additional 901 shares during the period. 65.25% of the stock is owned by institutional investors and hedge funds.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.